Relay Therapeutics
RLAY
RLAY
177 hedge funds and large institutions have $1.41B invested in Relay Therapeutics in 2023 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 55 increasing their positions, 57 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
4% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 57
3% less ownership
Funds ownership: 106.82% → 103.82% (-3%)
28% less call options, than puts
Call options by funds: $72K | Put options by funds: $100K
Holders
177
Holding in Top 10
3
Calls
$72K
Puts
$100K
Top Buyers
| 1 | +$17.7M | |
| 2 | +$17.2M | |
| 3 | +$14.9M | |
| 4 |
BlackRock
New York
|
+$13.7M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$11.6M |
Top Sellers
| 1 | -$35M | |
| 2 | -$16.3M | |
| 3 | -$16M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$12.1M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$11.9M |